WNPRC research led to the first successful Parkinson's gene therapy clinical trial
On March 17, 2011, Lancet Neurology published the report of the first successful randomized, double-blind phase II clinical trial of a gene therapy for Parkinson's or any neurologic disorder. The article cites as groundwork for this trial a 2006 rhesus monkey study led by Marina Emborg, with collaborators from UW-Madison and other institutions.
Emborg is a scientist at the Wisconsin National Primate Research Center (WNPRC) and an assistant professor in the department of Medical Physics at the University of Wisconsin-Madison. An M.D. and Ph.D., she has published numerous scientific journal articles on Parkinson’s disease research, as well as on the ethics associated with translating pre-clinical studies into clinical trials.
Read more on Dr. Emborg's latest research on Parkinson's disease:
- Science Daily, March 17, 2011
- Science Newsline Medicine, March 17, 2011
- Research Saves Magazine, Spring 2011 issue
- The Lancet Neurology (LeWitt et al, April 2011, published online March 17) via Science Direct, full article
- Journal of Cerebral Blood Flow Metabolism (Emborg et al, 2006) via PubMed, abstract
- Emborg Lab at the WNPRC
